April 7, 2017
JMA President Yoshitake Yokokura The government should encourage innovation in the pharmaceutical industry through tax cuts and subsidies, instead of the current price-maintenance premium scheme , Japan Medical Association (JMA) President Yoshitake Yokokura stressed on April 6. The leader of...read more